Drug Companies Target India For R&D Under New Patent Regime
At the same time, many global drug makers are bolstering their legal teams to prepare for possible legal battles with local generics makers, the Economic Times of India reported. Most large drug originators expect legal cost to continue to rise until at least 2008, when many of the legal issues arising from the new patent regime should be resolved...
To view the full article, register now.
Try Law360 FREE for seven days
Already a subscriber? Click here to login